- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The medication cycle of Lifnua tablets should be personalized according to the patient's condition and treatment response. It is usually recomm...
The course of treatment for Lifnua tablets should be dynamically adjusted based on the individual patient's condition and treatment response, w...
The medication cycle of Benambax for injection needs to be personalized according to the type of infection and the patient's immune status, usu...
Benambax for injection is usually not recommended for long-term use, and its course of treatment is designed with the goal of pathogen clearanc...
Evrysdi tablets are an oral medication used to treat spinal muscular atrophy (SMA), which increases functional SMN protein production by regula...
Evrysdi tablets, as an oral medication for the treatment of spinal muscular atrophy (SMA), exert their effects by regulating SMN2 gene splicing...
Encorafenib is an oral small molecule BRAF kinase inhibitor developed by Array Corporation in the United States and approved for market by the ...
Encorafenib is an oral BRAF kinase inhibitor used to treat malignant tumors carrying BRAF V600E/K mutations, including melanoma, colorectal can...
Lemboraxant is a novel dual orexin receptor antagonist primarily used to treat adult insomnia, particularly targeting symptoms of difficulty fa...
Lemboraxant is a novel dual orexin receptor antagonist specifically used to treat insomnia characterized by difficulty falling asleep or mainta...
